Niagen Bioscience, Inc. - NAGE
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 12
Latest filed: Mar 19, 2026
| Form | Count |
|---|---|
| 8-K | 6 |
| 4 | 4 |
| SCHEDULE 13G/A | 1 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Mar 19, 2026 | 8-K | Mar 19, 2026 | 0001386570-26-000017 | View |
| Mar 04, 2026 | 8-K | Mar 04, 2026 | 0001386570-26-000014 | View |
| Feb 26, 2026 | 8-K | Feb 24, 2026 | 0001386570-26-000003 | View |
| Feb 24, 2026 | 4 | Feb 19, 2026 | 0001628280-26-011159 | View |
| Feb 24, 2026 | 4 | Feb 19, 2026 | 0001628280-26-011160 | View |
| Feb 24, 2026 | 4 | Feb 19, 2026 | 0001628280-26-011162 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | — | 0000102909-26-000155 | View |
| Dec 22, 2025 | 8-K | Dec 18, 2025 | 0001386570-25-000030 | View |
| Nov 17, 2025 | 4 | Nov 14, 2025 | 0001834681-25-000005 | View |
| Nov 06, 2025 | 8-K | Nov 06, 2025 | 0001386570-25-000025 | View |
| Nov 04, 2025 | 8-K | Nov 04, 2025 | 0001386570-25-000021 | View |
| Oct 31, 2025 | SCHEDULE 13G | — | 0000102909-25-000236 | View |